ATRACURIUM BESYLATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Atracurium Besylate, and when can generic versions of Atracurium Besylate launch?
Atracurium Besylate is a drug marketed by Baxter Hlthcare, Baxter Hlthcare Corp, Eugia Pharma, Hikma, Hospira, Hospira Inc, Meitheal, Norvium Bioscience, Teva Parenteral, Watson Pharms Teva, and Watson Labs Inc. and is included in twenty-two NDAs.
The generic ingredient in ATRACURIUM BESYLATE is atracurium besylate. There are sixteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the atracurium besylate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Atracurium Besylate
A generic version of ATRACURIUM BESYLATE was approved as atracurium besylate by HIKMA on July 18th, 1997.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ATRACURIUM BESYLATE?
- What are the global sales for ATRACURIUM BESYLATE?
- What is Average Wholesale Price for ATRACURIUM BESYLATE?
Summary for ATRACURIUM BESYLATE
| US Patents: | 0 |
| Applicants: | 11 |
| NDAs: | 22 |
| Finished Product Suppliers / Packagers: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 101 |
| Clinical Trials: | 14 |
| Patent Applications: | 737 |
| DailyMed Link: | ATRACURIUM BESYLATE at DailyMed |
Recent Clinical Trials for ATRACURIUM BESYLATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Tanta University | N/A |
| Cairo University | Phase 4 |
| Theodor Bilharz Research Institute | Phase 4 |
Pharmacology for ATRACURIUM BESYLATE
| Drug Class | Nondepolarizing Neuromuscular Blocker |
| Physiological Effect | Neuromuscular Nondepolarizing Blockade |
Medical Subject Heading (MeSH) Categories for ATRACURIUM BESYLATE
Anatomical Therapeutic Chemical (ATC) Classes for ATRACURIUM BESYLATE
US Patents and Regulatory Information for ATRACURIUM BESYLATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baxter Hlthcare | ATRACURIUM BESYLATE | atracurium besylate | INJECTABLE;INJECTION | 074824-001 | Sep 30, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hospira | ATRACURIUM BESYLATE PRESERVATIVE FREE | atracurium besylate | INJECTABLE;INJECTION | 074741-001 | Mar 28, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hospira Inc | ATRACURIUM BESYLATE | atracurium besylate | INJECTABLE;INJECTION | 090761-001 | Oct 18, 2012 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Hikma | ATRACURIUM BESYLATE | atracurium besylate | INJECTABLE;INJECTION | 074901-001 | Jul 18, 1997 | AP | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
